Emetrol Cherry
NDC Package 68788-9801-1
Package Information
Emetrol Cherry is for maximum effectiveness never dilute or drink fluids of any kind immediately before or after taking this productadults and children 12 years of age and over: one to two tablespoonschildren 2 to under 12: one or two teaspoonsrepeat dose every 15 minutes or until distress subsidesdo not take more than 5 doses in 1 hour without consulting a doctor. Marketed by Preferred Pharmaceuticals, Inc, this product is identified by NDC 68788-9801.
Identification & Billing
- RxCUI: 318146 - dextrose 1.87 GM / fructose 1.87 GM / phosphoric acid 21.5 MG in 5 mL Oral Solution
- RxCUI: 318146 - fructose 374 MG/ML / glucose 374 MG/ML / phosphoric acid 4.3 MG/ML Oral Solution
- RxCUI: 318146 - dextrose 1.87 GM / fructose 1.87 GM / phosphoric acid 21.5 MG per 5 ML Oral Solution
- RxCUI: 809602 - Emetrol 1.87 GM / 1.87 GM / 21.5 MG in 5 mL Oral Solution
- RxCUI: 809602 - fructose 374 MG/ML / glucose 374 MG/ML / phosphoric acid 4.3 MG/ML Oral Solution [Emetrol]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68788 - Preferred Pharmaceuticals, Inc
- 68788-9801 - Emetrol Cherry
- 68788-9801-1 - 118 mL in 1 BOTTLE
- 68788-9801 - Emetrol Cherry
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68788-9801-1 identifies a specific commercial package of 118 ml in 1 bottle of Emetrol Cherry, labeled by Preferred Pharmaceuticals, Inc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Preferred Pharmaceuticals, Inc on April 23, 2012. The current certification is valid through December 31, 2017.
How is this Preferred Pharmaceuticals, Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68788980101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.